APA (7th ed.) Citation

Zhang, H., Yang, L., Zhu, Y., Yao, X., Zhang, S., Dai, B., . . . Ye, D. (2011). Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. The Prostate, 71(3), 326-331. https://doi.org/10.1002/pros.21246

Chicago Style (17th ed.) Citation

Zhang, Hai-Liang, et al. "Serum MiRNA-21: Elevated Levels in Patients with Metastatic Hormone-refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-based Chemotherapy." The Prostate 71, no. 3 (2011): 326-331. https://doi.org/10.1002/pros.21246.

MLA (9th ed.) Citation

Zhang, Hai-Liang, et al. "Serum MiRNA-21: Elevated Levels in Patients with Metastatic Hormone-refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-based Chemotherapy." The Prostate, vol. 71, no. 3, 2011, pp. 326-331, https://doi.org/10.1002/pros.21246.